Educational information, not medical advice — ask your doctor or midwife.
What is Acalypha psilostachya? It is a flowering shrub in the spurge family (Euphorbiaceae).
It grows wild in parts of tropical Africa. Healers there have used its leaves and roots in home remedies.
It is not a mainstream supplement. You will rarely see it on a shop shelf outside its home range. Most of it is picked fresh and used close to where it grows.
The plant is one of many Acalypha species. They look alike and share local names. Much of what is written about "Acalypha" may not apply to this exact plant.
Here is the honest verdict on evidence. There are no human trials of this species that we can point to.
Long use in a tradition shows that people valued a plant. It does not prove that the plant works, and it does not prove that it is safe.
This page treats it as a plant of traditional record with unknown effect and unknown risk. That is not the same as "harmless". It means no one has checked.
No one has shown how this plant acts in the human body. Anything below is a proposal, not a proven effect.
Researchers have screened other plants in the Acalypha genus. In test-tube work, some extracts slow the growth of certain bacteria and fungi. Some also mop up free radicals (unstable molecules that can damage cells).
In animal studies of related species, a few extracts eased swelling or lowered blood sugar. These were small lab studies. They used different plants, chiefly Acalypha indica and Acalypha wilkesiana.
Lab activity often fails to carry over into people. A compound must survive digestion, reach the right tissue, and do so at a safe dose. Most plant extracts fall at one of those steps.
So the fair summary is simple. The genus is of lab interest. This species has no tested mechanism in humans.
There is no standard commercial product. Use is mostly local and homemade.
Forms recorded in traditional use include: - Fresh leaves, crushed and applied to skin - Water decoctions or infusions of leaf or root - Dried, powdered leaf - Leaf juice, used on wounds or in the ear in some accounts
You may occasionally see dried herb or a tincture sold online as a botanical curiosity. These are not tested, graded or standardised. Labels on them are not checked by any health authority.
Mislabelling is a real risk. Acalypha species share local names and look similar. A bag sold under one name may hold another plant entirely.
Plants of the Acalypha genus have a long place in African folk medicine. Written records of them are thin and mostly recent. They come from plant-survey work, not from clinics.
Healers reportedly used leaf and root preparations for skin sores, coughs, stomach trouble and fever. Uses varied by region and by healer. Some accounts also describe ritual or veterinary use.
Acalypha psilostachya itself appears in name lists of African medicinal plants. The detail behind those entries is slim. Where a source names "Acalypha", it often does not say which species was used.
These are historical reports, written down by observers. They are not instructions, and this page does not present them as such.
Stop using it and get medical help if you notice any of these: - Dark or red-brown urine, pale skin, or sudden weakness and breathlessness - Yellow skin or eyes, or pain in your upper right belly - Swelling of the lips, tongue or throat, or trouble breathing - A spreading rash or blistering skin - Vomiting that will not stop, or severe stomach pain
Call emergency services for breathing trouble or throat swelling.
Also see a doctor if the problem you are treating is not improving. A fever, a cough or a sore that lasts needs proper assessment.
It is not approved as a medicine in the United States, the United Kingdom, the European Union, Canada or Australia. It is not a common food or a registered supplement, and anything sold under this name is unregulated raw plant material.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.